Mosterd, Charlotte M

Nephroprotective effects of GLP-1 receptor agonists: where do we stand? [electronic resource] - Journal of nephrology Oct 2020 - 965-975 p. digital

Publication Type: Journal Article; Review

1724-6059

10.1007/s40620-020-00738-9 doi


Cardiovascular Diseases--drug therapy
Diabetes Mellitus, Type 2--complications
Diabetic Nephropathies--drug therapy
Glucagon-Like Peptide-1 Receptor
Humans
Hypoglycemic Agents--adverse effects
Pharmaceutical Preparations